dapoxetine
Phase 1/2Completed 0 watching 0 views this week⚡ Active
41
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Premature Ejaculation
Conditions
Premature Ejaculation
Trial Timeline
Feb 1, 2011 → May 1, 2012
NCT ID
NCT01419470About dapoxetine
dapoxetine is a phase 1/2 stage product being developed by Yuhan for Premature Ejaculation. The current trial status is completed. This product is registered under clinical trial identifier NCT01419470. Target conditions include Premature Ejaculation.
Hype Score Breakdown
Clinical
13
Activity
8
Company
10
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01419470 | Phase 1/2 | Completed |
Competing Products
8 competing products in Premature Ejaculation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| PSD502, contains a mixture of lidocaine and prilocaine + Placebo | Shionogi | Phase 2/3 | 65 |
| Placebo + Cisapride | Johnson & Johnson | Approved | 85 |
| SHR7280；Ganirelix Acetate Injection simulant + SHR7280 simulant； Ganirelix Acetate Injection | Jiangsu Hengrui Medicine | Phase 3 | 77 |
| ranolazine | Gilead Sciences | Phase 2 | 51 |
| IX-01 + Placebo | ICON plc. | Phase 2 | 49 |
| Flecainide (monotherapy) | Brain Biotech | Pre-clinical | 15 |
| Tramadol Hydrochloride & Placebo | Bausch Health | Phase 3 | 72 |
| Tramadol Hydrochloride + Placebo | Bausch Health | Phase 3 | 72 |
Other Products from Yuhan
generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)Approved
85
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidApproved
85
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgApproved
85
Atorvastatin 20mg loading + Atorvastatin 80mg loadingApproved
85